TOP

News

Arkis BioSciences News

Med Device Online publishes editorial on innovative product development at Arkis

Med Device Online’s editor Bob Marshall examines the methodology of product development at Arkis BioSciences, and how Arkis is addressing unmet clinical needs.

 

Read More

Arkis progression to Innovation Campus covered by Knoxville Business Journal

The Knoxville Business Journal published the following announcement of the grand opening for Arkis BioSciences at the new UT Innovation Campus, adjacent to the Joint Institute for Advanced Materials.

 

Read More

Teknovation reports great progress at Arkis BioSciences

Technovation.biz published coverage today of the progress achieved by Arkis Biosciences.

 

Read More

Arkis BioSciences® opens state-of-the-art facility at Knoxville’s Innovation Campus

Arkis BioSciences was proud to announce our Grand Opening this morning at the Cherokee Farm Innovation Campus, a new high-tech facility at the University of Tennessee’s research and development campus, featuring the Joint Institute for Advanced Materials.

 

Read More

Arkis BioSciences® launches the new CerebroFlo™ EVD Catheter with Endexo® Technology at the 2017 Congress of Neurological Surgeons

Arkis BioSciences is launching the CerebroFlo™ EVD Catheter with Endexo® Technology at the 2017 Congress of Neurological Surgeons, booth 747. Demonstrations are available at the booth for the Single Pass Tunneling Guidewire®, the Subcutaneous Guidewire™, and the CerebroFlo EVD Catheter.

 

Read More

Interface Biologics Enters the Neurology Market with 510(k) Clearance of Arkis BioSciences® CerebroFlo™ EVD Catheter with Endexo® Technology

Interface Biologics Inc. (“IBI”), a privately held, commercial stage company developing innovative material science technologies that save lives and improve patient outcomes, is pleased to announce that Arkis BioSciences® has received 510(k) clearance from U.S. Food and Drug Administration (FDA) for its exclusive CerebroFlo™ EVD Catheter with IBI’s Endexo® technology.

 

Read More

Arkis BioSciences® achieves FDA clearance of its new CerebroFlo™ EVD Catheter with Endexo® Technology

Arkis BioSciences, a leading innovator in minimally invasive surgical instrumentation, has obtained FDA clearance of its new external ventricular drainage catheter, CerebroFlo™.  The CerebroFlo catheter has demonstrated a 99% reduction in thrombus accumulation in-vitro, and is indicated for temporary use in patients with elevated intracranial pressure, intraventricular hemorrhage, or hydrocephalic shunt infections. Arkis will debut […]

 

Read More

Arkis BioSciences selected as the Top Innovator at the 2017 New York Venture Summit

Arkis is honored to have been chosen as the Top Innovator at the 2017 NY Venture Summit, July 18-19th, 2017.  Be sure to visit us in the Big Apple and learn the latest news as Arkis continues to roll out its product portfolio advancing treatments for intracranial hypertension.

 

Read More

Arkis showcases new Subcutaneous Guidewire at the Los Angeles AANS Conference, April 24-26th at booth 2047.

Arkis BioSciences exhibits new Subcutaneous GuidewireTM, adding to its minimally invasive product line. Please visit the team now at booth 2047 of the AANS conference in Los Angeles to see the latest additions to the surgical portfolio, and receive an update on our new SureFloTM EVD catheters with Endexo® technology.

 

Read More

Arkis BioSciences Expands Clinical Use Of Its New Minimally Invasive Tunneling Guidewire™ Technology.

Single PassTM shunt workflow enables up to one-third less invasive shunt procedures in hydrocephalus patients.  Please see the full press release, or view our Surgical Innovations product site for more information on our minimally invasive Tunneling GuidewireTM.

 

Read More

Contact Us

Address: 1 Momentum Way, Knoxville, TN 37920 | Tel: (844) 247-5383 (toll free)

© 2013-2018  Arkis BioSciences Inc.  All rights reserved.   |   Privacy   |   Sitemap

Go to top